ALKERMES | ALKS - 市值

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	市值	更改		日
AbbVie	USD 403.83B		5.2B	2025-12
Acadia Pharmaceuticals	USD 4.52B		919M	2025-12
ALKERMES	USD 4.62B		333M	2025-12
Amgen	USD 176.25B		24.32B	2025-12
Biogen	USD 25.82B		5.28B	2025-12
BioMarin Pharmaceutical	USD 11.42B		1.02B	2025-12
Bristol-Myers Squibb	USD 109.81B		18.01B	2025-12
Coherus Biosciences	USD 172M		19M	2025-12
Eli Lilly	USD 1.02T		293.84B	2025-12
Gilead Sciences	USD 166.62B		14.34B	2026-04
Heron Therapeutics	USD 238M		7M	2025-12
Ionis Pharmaceuticals	USD 12.81B		2.39B	2025-12
J&J	USD 561.65B		17.5B	2026-04
Malin Corporation	EUR 142.92M		19.65M	2026-02
Merck	USD 261.26B		51.62B	2025-12
Nektar Therapeutics	USD 14.34B		13.48B	2026-04
Neurocrine Biosciences	USD 14.14B		218M	2025-12
Otsuka Holdings	JPY 4.82T		550.59B	2025-12
Ovoca Bio	EUR 6.12M		4.93M	2026-04
Pfizer	USD 141.57B		6.48B	2025-12
Regeneron Pharmaceuticals	USD 81.12B		21.53B	2025-12
Vertex Pharmaceuticals	USD 115.03B		14.61B	2025-12